Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 6 of 6

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract March 2012

Intravitreal Bevacizumab As An Adjuvant Agent To Plaque Brachytherapy Reduces Tumor Burden And Enhances The Resolution Of Exudative Detachment

Samuel K. Houston; Nisha Shah; Christina L. Decatur; Marcela Lonngi; William J. Feuer; Timothy G. Murray

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):3425.

ARVO Annual Meeting Abstract March 2012

2-deoxy-D-glucose (2-DG): In vivo Evaluation of Anti-angiogenic Impact on Retinoblastoma Tumor Vasculature

Nikesh N. Shah; Samuel Houston; Yolanda Piña; Timothy G. Murray; Christina L. Decatur; Jaime Merchan; Theodore Lampidis

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):1873.

ARVO Annual Meeting Abstract March 2012

Use of AMP-kinase Activator 5-Aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) in the Treatment of Retinoblastoma

Christina L. Decatur; Nikesh Shah; Yolanda Piña; Marcela Lonngi; Dien Pham; Samuel Houston; Timothy G. Murray

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):1875.

ARVO Annual Meeting Abstract April 2011

Evaluating the Glycolytic Pathway in Retinoblastoma: A Molecular Mechanistic Approach Using the Glycolytic Inhibitor 2-deoxy-D-glucose in vitro and in vivo

Christina L. Decatur; Yolanda Pina; Samuel Houston; Ludimila Cavalcante; Timothy Murray; Theodore Lampidis

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):2483.

ARVO Annual Meeting Abstract April 2011

Use of 2-fluorodeoxy-d-glucose (2-FDG) to Target the Chemoresistant, Hypoxic Cell Population in Advanced LHBetaTAg Retinal Tumors

Samuel K. Houston; Timothy G. Murray; Christina L. Decatur; Yolanda Pina; Ludimila Cavalcante; Theodore Lampidis

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):2487.

ARVO Annual Meeting Abstract April 2011

Characterization of Transgenic Mouse RPE Cultures

Nicole R. Congrove; Christina L. Decatur; J. Brett Stanton; Alan D. Marmorstein; Brian S. McKay

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):931.

Advertisement